MABWORKS
Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.
MABWORKS
Industry:
Biopharma Biotechnology Clinical Trials
Founded:
2003-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.mab-works.com
Total Employee:
11+
Status:
Active
Contact:
+86(0)01-87169780
Total Funding:
214.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apple Mobile Web Clips Icon Mobile Non Scaleable Content Nginx Euro IPv6 PHP PHP 7
Current Employees Featured
Investors List
Lake Bleu Capital
Lake Bleu Capital investment in Series C - Mabworks
CITIC Securities
CITIC Securities investment in Series C - Mabworks
Beijing E-town International Investment & Development
Beijing E-town International Investment & Development investment in Series C - Mabworks
BOCOM International
BOCOM International investment in Series C - Mabworks
Sealand Securities
Sealand Securities investment in Series C - Mabworks
Guangzhou Yuexiu Financial Holdings
Guangzhou Yuexiu Financial Holdings investment in Series C - Mabworks
LYZZ Capital
LYZZ Capital investment in Series C - Mabworks
CICC
CICC investment in Series C - Mabworks
SDIC Fund Management
SDIC Fund Management investment in Series C - Mabworks
Harvest Global Investments
Harvest Global Investments investment in Series B - Mabworks
Official Site Inspections
http://www.mab-works.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: hn.kd.ny.adsl
- IP address: 42.236.91.228
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
More informations about "Mabworks"
Company Overview - mab-works.com
Our mission is to translate scientific breakthroughs in immunology and biology into novel antibody therapies that target a wide range of autoimmune diseases and oncology, addressing …See details»
Mabworks - Crunchbase Company Profile & Funding
Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP …See details»
Mab Works
We have developed a differentiated pipeline of clinical-stage and preclinical drug candidates by leveraging our proprietary antibody discovery and development platforms. MIL62 is a novel 3rd …See details»
北京天广实生物技术股份有限公司
6 days ago · MBS314是一种针对多发性骨髓瘤的创新型GPRC5D/BCMA/CD3三特异性抗体，为多发性骨髓瘤患者提供潜在更优选解决方案。 我们的研发战略包括三类机制：激活NK细胞，重 …See details»
Mabworks Company Profile - Office Locations, Competitors, …
See insights on Mabworks including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Mabworks - Funding, Financials, Valuation & Investors - Crunchbase
Mabworks is funded by 13 investors. Lake Bleu Capital and CITIC Securities are the most recent investors. in funding over 3 rounds. Their latest funding was raised on Apr 16, 2020 from a …See details»
Mabworks Biotech - PitchBook
Developer of differential antibody drugs to serve cancer biology. The company specializes in developing pre-clinical and clinical tumor and autoimmune diseases-related drugs by translating the scientific breakthrough of …See details»
Mabworks Biotech - Overview, News & Similar companies
Apr 16, 2020 · View Mabworks Biotech (www.mab-works.com) location in Beijing, China , revenue, industry and description. Find related and similar companies as well as employees …See details»
Beijing Mabworks Biotech Co., Ltd. - synapse.zhihuiya.com
公司是国家级高新技术企业、北京市专精特新中小企业、北京市级企业科技研究开发机构、北京市工程实验室，并设有企业博士后工作站和院士专家工作站。 媒体交流请联系：PR@mab …See details»
Management Team - mab-works.com
Our core management team is composed of industry veterans with an average of more than 20 years of experience in the biopharmaceutical industry. Dr. Li is responsible for the overall management, business strategies, regulatory …See details»
Mabworks Biotech - Products, Competitors, Financials, Employees ...
Mabworks is a clinical stage biopharma company that develops antibody medication. It uses integrated technology platforms to develop, manufacture and commercialize therapeutic …See details»
Mabworks Biotech - VentureRadar
Website: http://www.mab-works.com/ Develops and manufactures therapeutic antibodies through fully-integrated technology platforms, with a pipeline of 15+ assets in clinical development …See details»
Monoclonal antibody therapy - Wikipedia
Monoclonal antibodies (mAbs) have varied therapeutic uses. It is possible to create a mAb that binds specifically to almost any extracellular target, such as cell surface proteins and cytokines.See details»
MABworks LLC - Facebook
MABworks is a 3-man custom carpentry company that specializes in full custom/niche projects.See details»
Technology Platforms - mab-works.com
Our ADCC-enhanced antibody platform is one of the leading platforms in the world to enhance NK-cell function through antibody glycosylation modification. It also meets GMP manufacturing …See details»
Monoclonal antibodies (MABs) | Immunotherapy - Cancer …
Some monoclonal antibodies (MABs) are a type of immunotherapy. They work by triggering the immune system and helping it to attack cancer. This page is about MABs that affect the …See details»
Management Advisory Board for the RCMP - Canada.ca
The MAB is an independent group of up to 13 external experts. It provides impartial advice based on its expertise, experience, and best judgement. The MAB establishes its own priorities, …See details»
Working at Mabworks
We aspire to become a globally integrated biopharmaceutical company by leveraging our differentiated pipeline and proprietary R&D platforms. We are looking for industry experts with …See details»
Home - MAB Community Services
MAB Community Services (MAB) is committed to creating opportunities and transforming the lives of individuals with a range of disabilities. Our goal is focused on providing the necessary …See details»
Milestones - mab-works.com
We aspire to become a globally integrated biopharmaceutical company by leveraging our differentiated pipeline and proprietary R&D platforms. In January, the first patient was enrolled …See details»